Bio-Pharmaceutical Logistics Market Report 2026

The bio-pharmaceutical logistics market size has grown rapidly in recent years. It will grow from $156.9 billion in 2025 to $173.98 billion in 2026 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to growth of biopharmaceutical production, expansion of global vaccine distribution, rising demand for temperature-sensitive drugs, development of specialized pharma warehouses, increasing clinical trial logistics activity.

The bio-pharmaceutical logistics market size is expected to see rapid growth in the next few years. It will grow to $259.32 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to expansion of personalized medicine distribution, rising investments in smart cold chain infrastructure, growing demand for cell and gene therapy logistics, increased adoption of digital tracking platforms, rising focus on sustainable pharma transportation. Major trends in the forecast period include increasing adoption of advanced cold chain solutions, rising use of real-time temperature monitoring, growing demand for specialized pharma logistics services, expansion of air freight for biologics, enhanced focus on regulatory compliance and traceability.

The growing adoption of biologics is expected to drive the expansion of the bio-pharmaceutical logistics market in the coming years. Biologics are advanced medicinal products derived from living organisms or containing components of living systems. Due to their high sensitivity, biologic drugs can interact with containers or packaging materials and often require strict cold or cryogenic storage conditions. Bio-pharmaceutical logistics supports the safe handling, storage, and transportation of biologics, plasma, vaccines, and other temperature-sensitive products, ensuring reliable access to life-saving healthcare treatments. For example, in January 2024, according to IQVIA, a US-based pharmaceutical clinical research company, global medicine usage increased by 14% over the past five years, with a further 12% growth expected by 2028, reaching an annual volume of 3.8 trillion defined daily doses. Therefore, the rising use of biologics is driving growth in the bio-pharmaceutical logistics market.

Companies operating in the bio-pharmaceutical logistics market are increasingly focusing on adopting advanced technologies such as IoT-enabled temperature-controlled packaging to improve shipment monitoring, traceability, and product integrity. IoT-enabled temperature-controlled packaging incorporates sensors and connectivity to continuously track conditions such as temperature and location throughout transit, enabling real-time environmental monitoring, asset tracking, and automated alerts in case of deviations. For instance, in April 2025, Cold Chain Technologies LLC, a US-based packaging company, introduced the CCT Tower Elite, an IoT-enabled reusable universal 1,600-liter temperature-controlled pallet shipper designed for global pharmaceutical and biotechnology shipments. The solution features integrated data loggers for near real-time temperature monitoring, live tracking, and asset management, and is compatible with both European and US pallets. The CCT Tower Elite enhances cost efficiency, operational visibility, and supply chain reliability for distributing temperature-sensitive products.

In March 2025, DHL Group GmbH, a Germany-based logistics and supply chain services provider, acquired CRYOPDP Inc. from Cryoport Inc. for an undisclosed amount. Through this acquisition, DHL aims to strengthen and expand its specialized pharmaceutical and healthcare logistics capabilities within its Life Sciences and Healthcare division, enhancing services for clinical trials, biopharmaceutical products, and advanced therapies. CRYOPDP Inc. is a US-based specialty healthcare courier that offers white-glove logistics and courier services focused on clinical trials, biopharma, and cell and gene therapies through a global network.

Major companies operating in the bio-pharmaceutical logistics market are Kuehne + Nagel International AG, FedEx Corporation, SF Express Co. Ltd., Dalsey Hillblom and Lynn, Kerry Logistics Network Limited, AmerisourceBergen Corporation, United Parcel Service of America Inc., DB Schenker, Agility Public Warehousing Company K.S.C.P., C.H. Robinson Worldwide Inc., Ceva Logistics, Nippon Express, GEODIS S.A., Air Canada Cargo, World Courier Inc., QuickSTAT Global Life Science Logistics Inc., Marken, Biocair, Almac Group, PCI Pharma Services Holdings LLC, Cryoport Inc., MNX Global Logistics LLC., Movianto, Clinical Trial Logistics, Thermo Fisher Scientific, World Courier Management Inc., Cardinal Health Inc., Parexel International Corporation.

North America was the largest region in the bio-pharmaceutical logistics market share in 2025. The regions covered in the bio-pharmaceutical logistics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bio-pharmaceutical logistics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biopharmaceutical logistics market includes revenues earned by entities by providing road shipping and rail shipping biopharmaceutical logistics services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.